Life Science & Medical Technology

Computer simulations using the Fugaku supercomputer pinpointed medications to treat tapeworm and other parasites as being possible candidates against COVID-19 infection.

Irradiation from deep ultraviolet LED light renders the novel coronavirus inactive, according to what could be trailblazing research.

The Robert Koch Foundation in Germany announced that the Robert Koch Award 2020 goes to Prof. Shimon Sakaguchi (Experimental Immunology, IFReC).

Medical startup AnGes Inc. said Tuesday it has begun Japan’s first clinical test on humans of a potential vaccine for the new coronavirus at an Osaka hospital.

Researchers have found that elderly people in Japan who are socially active tend to have good eyesight and that visual acuity helps determine the level of social participation for senior citizens. 

A team of researchers, led by Yoshimune Hiratsuka of the Department of Ophthalmology at Juntendo University Graduate School of Medicine, recently published the results of a study on the relationship between visual acuity and social participation in the Social Science and Medicine journal.

The team conducted a survey in 2016 of about 22,000 people who were aged 65 and older.

Japan’s first clinical trial using induced pluripotent stem (iPS) cells to treat cancer patients is expected to start in August, raising hopes for a breakthrough against the leading cause of death in the country.

A Japanese research team will begin a clinical trial this month of a blood test for early diagnosis of Alzheimer's disease by detecting abnormal proteins linked to it.

Omron has begun global sales of automated carrier robots fitted with ultraviolet lights or disinfectant sprayers that can sanitize hospitals and schools to prevent coronavirus infections, the Japanese company said Friday.

The head of Fast Retailing has pledged a total of 10 billion yen ($93 million) to Kyoto University to fund research into treatments for the new coronavirus and other communicable diseases.

Japan's Rohto Pharmaceutical said Tuesday it plans to launch clinical trials in August for a stem cell-based treatment for patients suffering severe symptoms induced by the novel coronavirus.